The American Academy of Pediatrics (AAP) has released an official position paper announcing their support for decriminalizing cannabis possession, as well as rescheduling cannabis so that children with debilitating conditions can use the medicine, and so that more studies can be conducted.
“The AAP strongly supports the decriminalization of marijuana use and encourages pediatricians to advocate for laws that prevent harsh criminal penalties for possession or use of marijuana.”, says Dr. Seth Ammerman, a clinical professor in pediatrics at Stanford University and the position paper’s lead author. “A focus on treatment for adolescents with marijuana use problems should be encouraged, and adolescents with marijuana use problems should be referred to treatment.”
The group also supports rescheduling cannabis from a Schedule 1 drug to a Schedule 2 drug, which would open the way for its medical use and further research.
“A Schedule 1 listing means there’s no medical use or helpful indications, but we know that’s not true because there has been limited evidence showing [marijuana] may be helpful for certain conditions in adults,” says Dr. Ammerman. “By placing this on Schedule 2, it would allow the FDA to be involved [in pediatric research] as the agency is in any study. Unless scheduling changes, this won’t happen. And there could be therapeutic benefits.”
The group’s official position paper can be found by clicking here.